← Back
$KYMR All transactions

Kymera Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

5,000

Price

$0

Filed

Jun 3

Insider

Name

Esposito Pamela

Title

CIK

0001744425

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,127

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2024 adopted by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | The shares underlying this stock option are fully vested and exercisable.

Filing Info

Accession No.

0000950170-25-081201

Form Type

4

Issuer CIK

0001815442

Esposito Pamela's History

Date Ticker Type Value
2025-06-25 KYMR A $0
2025-06-03 KYMR M $148K
2025-06-03 KYMR $245K
2025-06-03 KYMR M $0

Other Insiders at KYMR (90d)

Insider Bought Sold Last
Chadwick Jeremy G
Chief Operating Officer
$11.5M 2026-04-15
Booth Bruce $855K 2026-04-15
Ridloff Elena $1.0M 2026-04-01
Goodman Noah
Chief Business Officer
$1.0M 2026-04-14